Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy

BACKGROUND: The proposed use of bevacizumab with radiotherapy/temozolomide for newly diagnosed glioblastoma raised potential safety concerns. Bevacizumab has been linked with stroke, bleeding events, and wound-healing complications in other tumor types; these events are of particular concern for gli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Saran, Frank, Chinot, Olivier L., Henriksson, Roger, Mason, Warren, Wick, Wolfgang, Cloughesy, Timothy, Dhar, Sunita, Pozzi, Emanuela, Garcia, Josep, Nishikawa, Ryo
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896538/
https://ncbi.nlm.nih.gov/pubmed/26809751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov300
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados